Document is current
Any future updates will be listed below
-
Authors
Yasuda, Yuto https://orcid.org/0000-0002-5703-4119
Ozasa, Hiroaki
Kim, Young Hak
Yamazoe, Masatoshi
Ajimizu, Hitomi
Yamamoto Funazo, Tomoko
Nomizo, Takashi
Tsuji, Takahiro https://orcid.org/0000-0002-5706-8300
Yoshida, Hironori
Sakamori, Yuichi
Nakajima, Naoki
Menju, Toshi
Yoshizawa, Akihiko
Date, Hiroshi
Hirai, Toyohiro
-
Funding
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (19J12545)
- License Information
-
More Information
Article History
Received: 26 September 2019
Revised: 24 February 2020
Accepted: 25 February 2020
First Online: 9 March 2020
Conflict of interest
: T.H. is supported by Chugai Pharmaceutical Co., Ltd. Y.H.K. is supported by Chugai Pharmaceutical Co., Ltd., AstraZeneca K.K. (Osaka, Japan), Ono Pharmaceutical Co., Ltd. (Osaka, Japan), Bristol-Myers Squibb K.K. (Tokyo, Japan), Boehringer Ingelheim Japan, Inc. (Tokyo, Japan), and Eli Lilly Japan K.K (Kobe, Japan) as a honorarium recipient. H.D. is supported by Adachi Co., Ltd. (Osaka, Japan), TAIHO Pharmaceutical Co., Ltd. (Tokyo, Japan).
